Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

Cancer Research 68, 1362-1368, March 1, 2008. doi: 10.1158/0008-5472.CAN-07-2912
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Bemis, L. T.
Right arrow Articles by Robinson, W. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bemis, L. T.
Right arrow Articles by Robinson, W. A.

Molecular Biology, Pathobiology, and Genetics

MicroRNA-137 Targets Microphthalmia-Associated Transcription Factor in Melanoma Cell Lines

Lynne T. Bemis1, Robert Chen1, Carol M. Amato1, Elizabeth H. Classen1, Steven E. Robinson1, David G. Coffey1, Paul F. Erickson1, Yiqun G. Shellman2 and William A. Robinson1

1 Division of Medical Oncology and 2 Department of Dermatology, University of Colorado Denver School of Medicine, Aurora, Colorado

Requests for reprints: William A. Robinson, Division of Medical Oncology, University of Colorado Denver School of Medicine, Campus Box 8117, P.O. Box 6511, Aurora, CO 80045. E-mail: William.Robinson{at}uchsc.edu.

Key Words: MITF • melanoma • microRNA • miR-137 • VNTR

Micropthalmia-associated transcription factor (MITF) is the master regulator of melanocyte development, survival, and function. Frequent alteration in the expression of MITF is detected in melanoma, but the mechanism(s) underlying the alteration in expression have not been completely determined. In these studies, we have identified microRNA-137 (miR-137) as a regulator of MITF expression. The genomic locus of miR-137 at chromosome 1p22 places it in a region of the human genome previously determined to harbor an allele for melanoma susceptibility. Here, we show that expression of mature miR-137 in melanoma cell lines down-regulates MITF expression. Further, we have identified a 15-bp variable nucleotide tandem repeat located just 5' to the pre-miR-137 sequence, which alters the processing and function of miR-137 in melanoma cell lines. [Cancer Res 2008;68(5):1362–8]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2008 by the American Association for Cancer Research.